Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Capita secures £107m Northern Ireland contract extension

(Sharecast News) - Capita announced on Tuesday that it has secured a £107m contract extension with the Education Authority of Northern Ireland, under which it will continue providing IT services to over 1,100 schools across the region. The London-listed firm said the two-year extension would run from 1 April 2025 to 31 March 2027, and include an option to extend by a further two years on a one-plus-one basis.

It said the agreement would extend its 13-year relationship with the Education Authority and cover the ongoing delivery of managed IT and application services to primary, secondary, special educational needs, and nursery schools.

The contract included the provision of computer hardware and software, IT consultancy, and a range of associated support services.

Capita said the deal aligned with its strategy to enhance the delivery of complex public services at scale through the integration of people, processes and technology, while improving user experience for both school staff and pupils.

"We look forward to continuing our long-standing partnership with the Education Authority of Northern Ireland, and remain incredibly proud to be delivering essential services that support learning and education across Northern Ireland," said Capita Public Service chief executive officer Richard Holroyd.

At 0809 BST, shares in Capita were up 2.54% at 13.31p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.